臨床外科71巻5号

2016年05月発行

特集 外科臨床研究のノウハウと重要研究の総まとめ Part2：押さえておきたい外科臨床研究の総まとめ

GIST

著者： 岩槻政晃¹ 蔵重淳二¹ 吉田直矢¹ 馬場秀夫¹

所属機関： ¹熊本大学大学院消化器外科学

ページ範囲：P.594 - P.597

【ポイント】
◆切除可能GISTに対して，外科的切除が原則であり，より低侵襲な手術の開発も試みられている．
◆高リスク症例に対してはイマチニブによる術後補助療法が推奨される．
◆術前補助療法は，投与薬剤，用量・期間，効果判定のタイミングなどの問題点がある．
◆転移・再発GISTには外科的治療と薬物治療による集学的治療が必要である．

参考文献

1）日本癌治療学会，日本胃癌学会，GIST研究会（編）：GIST診療ガイドライン，第3版．金原出版．2014

2）Bischof DA, Kim Y, Dodson R, et al：Open versus minimally invasive resection of gastric GIST：a multi-institutional analysis of short- and long-term outcomes. Ann Surg Oncol 21：2941-2948, 2014

3）De Vogelaere K, Van Loo I, Peters O, et al：Laparoscopic resection of gastric gastrointestinal stromal tumors（GIST）is safe and effective, irrespective of tumor size. Surg Endosc 26：2339-2345, 2012

4）Honda M, Hiki N, Nunobe S, et al：Long-term and surgical outcomes of laparoscopic surgery for gastric gastrointestinal stromal tumors. Surg Endosc 28：2317-2322, 2014

5）Wu SD, Kong J, Su Y, et al：Safety and application of transumbilical single-incision laparoscopic gastrectomy for GIST：SILS in benign gastric disease. Surg Innov 20：365-369, 2013

6）Hiki N, Yamamoto Y, Fukunaga T, et al：Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc 22：1729-1735, 2008

7）Ntourakis D, Mavrogenis G：Cooperative laparoscopic endoscopic and hybrid laparoscopic surgery for upper gastrointestinal tumors：Current status. World J Gastroenterol 21：12482-12497, 2015

8）Eisenberg BL, Harris J, Blanke CD, et al：Phase Ⅱ trial of neoadjuvant/adjuvant imatinib mesylate（IM）for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor（GIST）：early results of RTOG 0132/ACRIN 6665. J Surg Oncol 99：42-47, 2009

9）Wang D, Zhang Q, Blanke CD, et al：Phase Ⅱ trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors：long-term follow-up results of Radiation Therapy Oncology Group 0132. Ann Surg Oncol 19：1074-1080, 2012

10）Rutkowski P, Gronchi A, Hohenberger P, et al：Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors（GIST）：the EORTC STBSG experience. Ann Surg Oncol 20：2937-2943, 2013

11）ESMO/European Sarcoma Network Working Group：Gastrointestinal stromal tumors：ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23（Suppl 7）：vii49-55, 2012

12）Nishida T, Shirao K, Sawaki A, et al：Efficacy and safety profile of imatinib mesylate（ST1571）in Japanese patients with advanced gastrointestinal stromal tumors：a phase Ⅱ study（STI571B1202）. Int J Clin Oncol 13：244-251, 2008

13）Bonvalot S, Eldweny H, Pechoux CL, et al：Impact of surgery on advanced gastrointestinal stromal tumors（GIST）in the imatinib era. Ann Surg Oncol 13：1596-1603, 2006

14）Haller F, Detken S, Schulten HJ, et al：Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours（GISTs）with respect to imatinib resistance caused by secondary KIT mutations. Ann Surg Oncol 14：526-532, 2007

15）Le Cesne A, Van Glabbeke M, Verweij J, et al：Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate：the intergroup EORTC-ISG-AGITG phase Ⅲ trial. J Clin Oncol 27：3969-3974, 2009

16）Choi H, Charnsangavej C, Faria SC, et al：Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate：proposal of new computed tomography response criteria. J Clin Oncol 25：1753-1759, 2007

17）von Mehren M, Randall RL, Benjamin RS, et al：Gastrointestinal stromal tumors, version 2.2014. J Natl Compr Canc Netw 12：853-862, 2014

18）Joensuu H, Eriksson M, Sundby Hall K, et al：One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor：a randomized trial. JAMA 307：1265-1272, 2012

19）Blanke CD：Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors. JAMA 307：1312-1314, 2012

20）Bauer S, Rutkowski P, Hohenberger P, et al：Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib--analysis of prognostic factors（EORTC-STBSG collaborative study）. Eur J Surg Oncol 40：412-419, 2014

21）Turley RS, Peng PD, Reddy SK, et al：Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer 118：3571-3578, 2012

22）ESMO/European Sarcoma Network Working Group：Gastrointestinal stromal tumours：ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25（Suppl 3）：iii21-26, 2014